title: Comparison of membranes used in the treatment of end-stage renal failure.
authors.affiliation: Department of Medicine, Medical School, University of Newcastle upon Tyne, United Kingdom.
authors.forename: N A
authors.initials: NA
authors.lastname: Hoenich
authors.forename: S C
authors.initials: SC
authors.lastname: Stenton
authors.forename: C
authors.initials: C
authors.lastname: Woffindin
authors.forename: D
authors.initials: D
authors.lastname: Levett
authors.forename: S
authors.initials: S
authors.lastname: Fawcett
authors.forename: M
authors.initials: M
authors.lastname: Quereshi
authors.forename: J S
authors.initials: JS
authors.lastname: Tapson
authors.forename: M K
authors.initials: MK
authors.lastname: Ward
mesh_terms: D001672:Biocompatible Materials; D003167:Complement Activation; D006801:Humans; D007688:Kidneys, Artificial / Q000009:adverse effects; D007970:Leukopenia / Q000209:etiology; D008567:Membranes, Artificial; D014165:Transfer Factor / Q000097:blood
chemical_list: D001672:Biocompatible Materials; D008567:Membranes, Artificial; D014165:Transfer Factor